Tead1aは,TEAD1a/YAP-Notch1-Spi1/Cebpα軸を通じてトランスクリプションプライミングを開始し,中性粒子の運命を促進する
PubMedで要約を見る
まとめ
この要約は機械生成です。研究者は,中性粒子の発育に重要なトランスクリプション強化関連ドメイン1a (TEAD1a) を特定しました. この早期のレギュラーをターゲットにすることで,中性粒子の減少 (中性粒子の数値低下) を治療するための新しい戦略が提供されます.
科学分野
- 血液学
- 発達生物学
- 分子遺伝学
背景
- 臨床的な中性子減少は中性子細胞の生産が低下したことから生じ,現在のG-CSFのような治療は発達の遅い段階で作用する.
- 現存する治療法は,潜在的に機能不全の中性粒子の前駆体を標的とするため,限界に直面しています.
研究 の 目的
- 中性粒子の発達の早期作用分子調節体を特定する.
- 耐性中性病の新たな治療目標を探求する
主な方法
- ゼブラフィッシュのモデルを使って ニュートロフィルの系統の仕様を調べました
- TEAD1aとYAP1の機能を研究するために遺伝的アブレーションとタンパク質の相互作用を妨害した.
- 骨髄原菌の特異化に関与するシグナル伝達経路に関するメカニズム的研究を行った.
主要な成果
- TEAD1aは,血液生成幹細胞の形成前に中性粒子の系統の特異化のための転写プライミングを開始することが判明しました.
- TEAD1aの遺伝的障害またはYAP1との相互作用は重度の中性不全を引き起こした.
- TEAD1a/ YAP1複合体は,Spi1/ Cebpαカスケードの活性化により,Notch1シグナル伝達を強化することが示された.
結論
- TEAD1aは,早期の中性粒子の発達を指揮する進化的に重要な役割を果たしています.
- この研究は 骨髄系へのコミットメントの 超早期の規制ノードを明らかにしています
- TEAD1aをターゲットにすることで,機能的な中性粒子を生成し,中性粒子の減少症を治療する有望な戦略が提供されます.
関連する概念動画
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Commitment is the process whereby stem cells:
lose their ability to form all cell types and
irreversibly change into a specific type.
The multipotent hematopoietic stem cells, (HSCs), differentiate into the multipotent hematopoietic progenitor cells, (HPCs). The HPCs express many lineage-specific cytokine receptors. Each of these receptors binds specific cytokines, activates distinct signaling pathways, and expresses a particular gene set. The HPCs further differentiate to...
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
Initiation is the first step of transcription in eukaryotes. Prokaryotic RNA Polymerase (RNAP) can bind to the template DNA and start transcribing. On the other hand, transcription in eukaryotes requires additional proteins, called transcription factors, to first bind to the promoter region in the DNA template. This binding helps recruit the specific RNAP that can assemble on the DNA and start transcription.
The promoters and enhancers and their accessory proteins allow tight regulation of...

